Drugs News and Research

RSS

Researchers discover potential Achilles heel of pediatric acute myeloid leukemia

Researchers at Baylor College of Medicine and Texas Children's Hospital have uncovered a potential Achilles heel of acute myeloid leukemia (AML) in children that could lead to new treatments for this devastating disease.

23 Sep 2021

Increased signaling by sonic hedgehog protein can inhibit LID in Parkinson's patients

Levodopa, or L-dopa, is considered the most effective treatment for Parkinson's disease today. After a few years of treatment, however, almost all patients develop a debilitating side-effect called L-dopa induced dyskinesia, or LID, which causes involuntary movements in the limbs, face, and torso. Deep brain stimulation can alleviate LID, but the procedure is highly invasive and not all patients are eligible.

23 Sep 2021

Study finds rise in methamphetamine-involved overdose deaths from 2015 to 2019

Overdose deaths involving methamphetamine nearly tripled from 2015 to 2019 among people ages 18-64 in the United States, according to a study by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

22 Sep 2021

Gram-positive and -negative bacteria found to be involved in periodontal bone loss

Mouths are filthy, harboring the second largest microbiome of the human body. Some bacteria can help break down food, among other responsibilities; other bacteria can travel into the mouth on food, fingers, pen caps and more to contribute to gum disease and other oral infections.

22 Sep 2021

The role of nanomaterials during the COVID-19 pandemic

A new review published in Rare Metals has focused on the applications of nanomaterials to fight the ongoing COVID-19 pandemic.

22 Sep 2021

COVID-19 vaccination in IBD patients

In this review, researchers reviewed all published research related to Phase 1/2 and/or Phase 3 and 4 studies of SARS-CoV-2 vaccinations.

22 Sep 2021

SARS-CoV-2 genome signature leads to replicative advantage in presence of Remdesivir

A new study indicates that low-level resistance of SARS-CoV-2 to remdesivir is not widespread and dissimilar to other RNA viruses revealing evolutionary predictability of this pandemic virus.

22 Sep 2021

Public health experts ‘flabbergasted’ that Biden still hasn’t picked an FDA chief

President Joe Biden's failure to name someone to lead the Food and Drug Administration, more than 10 months after the election, has flummoxed public health experts who say it's baffling for the agency to be without a permanent leader during a national health crisis.

22 Sep 2021

At an overrun ICU, ‘the problem is we are running out of hallways’

Nurses fill the hospital room to turn a patient from his stomach to his back. The ventilator forcing air into him is most effective when he's on his stomach, so he is in that position most hours of the day, sedated and paralyzed by drugs.

22 Sep 2021

New cohort of startup companies chosen for first-of-its-kind BlueSwell incubator program

SeaAhead, Inc. and the New England Aquarium have chosen a new cohort of startup companies for BlueSwell, a first-of-its-kind incubator program in the Northeast focused on supporting early-stage entrepreneurship in Bluetech.

22 Sep 2021

Consumption of common antibiotic during pregnancy can reduce low birth weight and premature births

A common antibiotic has been found to reduce low birth weight and premature births, if taken during pregnancy, in countries where malaria is endemic, according to a research review.

22 Sep 2021

Compound extracted from orchid could be a potential treatment option for prostate cancer

Research led by the Centenary Institute has found that a compound extracted from a commonly cultivated orchid could be a potential new treatment option for prostate cancer.

22 Sep 2021

Discovery of genes opens the door to new treatments for obesity

Promising news in the effort to develop drugs to treat obesity: University of Virginia scientists have identified 14 genes that can cause and three that can prevent weight gain.

22 Sep 2021

Rice bioengineer receives $1.9 million NIH grant to improve time-release drugs

Time-released drugs are about to get a geometry lesson, thanks to bioengineers at Rice University.

21 Sep 2021

Severe tinnitus following SARS-CoV-2 infection

A 49-year-old male with a history of COVID-19 presents with tinnitus.

21 Sep 2021

Nasal drugs show success in slowing Parkinson's disease progression in mice

Potential new treatments for Parkinson's disease developed by researchers at Rush University Medical Center have shown success in slowing progression of the disease in mice.

21 Sep 2021

Researchers create a living bioengineered nerve circuit to tackle opioid overdose crisis

In 2019, nearly 50,000 people in the United States died from opioid overdoses, bringing the total of number of deaths from the opioid crisis to half a million over the past 10 years, according to the U.S. Centers for Disease Control.

21 Sep 2021

Researchers provide structural insights into HCV receptor binding and entry

In a new paper published in Nature, scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, describe the structure of a key protein on the surface of the hepatitis C virus (HCV) and how it interacts with its receptor found on some human cells.

21 Sep 2021

Study outlines a baseline bundle of care interventions for critically ill patients

Critical illness results in millions of deaths globally every year, many of which could be avoided with basic, life-saving care. Now, a new study led by researchers at Karolinska Institutet in Sweden outlines a baseline bundle of care interventions that global experts agree should be available for all critically ill patients. The study, published in the journal BMJ Global Health, provides a blueprint for hospitals on how to reduce preventable deaths, including from COVID-19.

21 Sep 2021

Researchers pioneer simple but revolutionary approach to early Alzheimer's diagnosis

A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.

21 Sep 2021

Drugs News and Research

Researchers discover potential Achilles heel of pediatric acute myeloid leukemia

Increased signaling by sonic hedgehog protein can inhibit LID in Parkinson's patients

Study finds rise in methamphetamine-involved overdose deaths from 2015 to 2019

Gram-positive and -negative bacteria found to be involved in periodontal bone loss

The role of nanomaterials during the COVID-19 pandemic

COVID-19 vaccination in IBD patients

SARS-CoV-2 genome signature leads to replicative advantage in presence of Remdesivir

Public health experts ‘flabbergasted’ that Biden still hasn’t picked an FDA chief

At an overrun ICU, ‘the problem is we are running out of hallways’

New cohort of startup companies chosen for first-of-its-kind BlueSwell incubator program

Consumption of common antibiotic during pregnancy can reduce low birth weight and premature births

Compound extracted from orchid could be a potential treatment option for prostate cancer

Discovery of genes opens the door to new treatments for obesity

Rice bioengineer receives $1.9 million NIH grant to improve time-release drugs

Severe tinnitus following SARS-CoV-2 infection

Nasal drugs show success in slowing Parkinson's disease progression in mice

Researchers create a living bioengineered nerve circuit to tackle opioid overdose crisis

Researchers provide structural insights into HCV receptor binding and entry

Study outlines a baseline bundle of care interventions for critically ill patients

Researchers pioneer simple but revolutionary approach to early Alzheimer's diagnosis

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News